Cite
Donor's graft ex vivo T‐cell depletion with fludarabine reduces graft‐versus‐host disease signs and improves survival after intestinal transplantation – an experimental study.
MLA
Vela, Maria, et al. “Donor’s Graft Ex Vivo T‐cell Depletion with Fludarabine Reduces Graft‐versus‐host Disease Signs and Improves Survival after Intestinal Transplantation – an Experimental Study.” Transplant International, vol. 33, no. 10, Oct. 2020, pp. 1302–11. EBSCOhost, https://doi.org/10.1111/tri.13672.
APA
Vela, M., Stringa, P., González, N. P., Machuca, M., Pascual, M. B., Mestre, C., Arreola, N. M., Papa, G. R., Navarro, Z. A., Pires, L. S. C., Andrés, A. M., Hernández, O. F., & Pérez, M. A. (2020). Donor’s graft ex vivo T‐cell depletion with fludarabine reduces graft‐versus‐host disease signs and improves survival after intestinal transplantation – an experimental study. Transplant International, 33(10), 1302–1311. https://doi.org/10.1111/tri.13672
Chicago
Vela, Maria, Pablo Stringa, Navarro, Pablo González, Mariana Machuca, Miguel, Bárbara Pascual, Carmen Mestre, Nidia M. Arreola, et al. 2020. “Donor’s Graft Ex Vivo T‐cell Depletion with Fludarabine Reduces Graft‐versus‐host Disease Signs and Improves Survival after Intestinal Transplantation – an Experimental Study.” Transplant International 33 (10): 1302–11. doi:10.1111/tri.13672.